Published in Emerg Infect Dis on April 01, 2004
Genomic signatures of human versus avian influenza A viruses. Emerg Infect Dis (2006) 3.51
A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol (2009) 2.94
Codon conservation in the influenza A virus genome defines RNA packaging signals. Nucleic Acids Res (2007) 2.24
Laboratory-based surveillance and molecular epidemiology of influenza virus in Taiwan. J Clin Microbiol (2005) 1.26
Differential localization and function of PB1-F2 derived from different strains of influenza A virus. J Virol (2010) 1.17
Influenza A virus PB1-F2 gene. Emerg Infect Dis (2006) 0.93
Simplified large-scale Sanger genome sequencing for influenza A/H3N2 virus. PLoS One (2013) 0.92
A novel cytotoxic sequence contributes to influenza A viral protein PB1-F2 pathogenicity and predisposition to secondary bacterial infection. J Virol (2013) 0.88
Computational analysis and mapping of novel open reading frames in influenza A viruses. PLoS One (2014) 0.83
Surveillance in Eastern India (2007-2009) revealed reassortment event involving NS and PB1-F2 gene segments among co-circulating influenza A subtypes. Virol J (2012) 0.78
Non-avian animal reservoirs present a source of influenza A PB1-F2 proteins with novel virulence-enhancing markers. PLoS One (2014) 0.76
Role of Autophagy and Apoptosis in the Postinfluenza Bacterial Pneumonia. Biomed Res Int (2016) 0.75
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47
Evolution and ecology of influenza A viruses. Microbiol Rev (1992) 39.99
Structural features in eukaryotic mRNAs that modulate the initiation of translation. J Biol Chem (1991) 11.92
A novel influenza A virus mitochondrial protein that induces cell death. Nat Med (2001) 9.90
Ecological and immunological determinants of influenza evolution. Nature (2003) 7.60
Role of two of the influenza virus core P proteins in recognizing cap 1 structures (m7GpppNm) on RNAs and in initiating viral RNA transcription. Proc Natl Acad Sci U S A (1981) 5.10
DNASTAR's Lasergene sequence analysis software. Methods Mol Biol (2000) 4.52
Improvements in protein secondary structure prediction by an enhanced neural network. J Mol Biol (1990) 4.10
Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus. Proc Natl Acad Sci U S A (2002) 4.02
Phylogenetic analysis using PHYLIP. Methods Mol Biol (2000) 3.27
The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function. J Virol (2003) 2.76
Typing and subtyping of influenza viruses in clinical samples by PCR. J Clin Microbiol (1995) 2.72
Type- and subtype-specific detection of influenza viruses in clinical specimens by rapid culture assay. J Clin Microbiol (1995) 1.80
The large P proteins of influenza A viruses are composed of one acidic and two basic polypeptides. Virology (1980) 1.71
Update: influenza activity--United States and worldwide, 1997-98 season, and composition of the 1998-99 influenza vaccine. MMWR Morb Mortal Wkly Rep (1998) 1.42
Differential induction of cytotoxicity and apoptosis by influenza virus strains of differing virulence. J Gen Virol (1997) 1.39
Update: influenza activity--United States and worldwide, 1999-2000 season, and composition of the 2000-01 influenza vaccine. MMWR Morb Mortal Wkly Rep (2000) 1.22
Genetic and antigenic analysis of the first A/New Caledonia/20/99-like H1N1 influenza isolates reported in the Americas. Emerg Infect Dis (2002) 1.12
Bioinformatics in protein analysis. EXS (2000) 1.07
Update: influenza activity--United States and worldwide, 2000-01 season, and composition of the 2001-02 influenza vaccine. MMWR Morb Mortal Wkly Rep (2001) 1.05
Update: influenza activity--United States and worldwide, 1996-97 season, and composition of the 1997-98 influenza vaccine. MMWR Morb Mortal Wkly Rep (1997) 1.03
Update: influenza activity--United States and worldwide, 1998-99 season, and composition of the 1999-2000 influenza vaccine. MMWR Morb Mortal Wkly Rep (1999) 1.00
Update: influenza activity--United States and Worldwide, 1995-96 season, and composition of the 1996-97 influenza vaccine. MMWR Morb Mortal Wkly Rep (1996) 0.99
Update: influenza activity--worldwide, 1996. MMWR Morb Mortal Wkly Rep (1996) 0.94
Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A:H3N2 viruses isolated in Canada. J Med Virol (2002) 0.93
Update: influenza activity--United States, 1999-2000 season. MMWR Morb Mortal Wkly Rep (2000) 0.86
The haemagglutinin gene, but not the neuraminidase gene, of 'Spanish flu' was a recombinant. Philos Trans R Soc Lond B Biol Sci (2001) 0.83
[Influenza virus genome structure and encoded proteins]. Nihon Rinsho (1997) 0.80
From the Centers for Disease Control and Prevention. Update: influenza activity--worldwide, 1996. JAMA (1996) 0.79
From the Centers for Disease Control and Prevention. Update: influenza activity--United States, 1999-2000 season. JAMA (2000) 0.78
Genomic signatures of human versus avian influenza A viruses. Emerg Infect Dis (2006) 3.51
Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan. Pediatrics (2002) 2.94
Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med (2007) 2.56
The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype choleraesuis. N Engl J Med (2002) 2.39
Novel swine-origin influenza virus A (H1N1): the first pandemic of the 21st century. J Formos Med Assoc (2009) 2.28
Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA (2004) 2.20
Adjuvant treatment with a mammalian target of rapamycin inhibitor, sirolimus, and steroids improves outcomes in patients with severe H1N1 pneumonia and acute respiratory failure. Crit Care Med (2014) 2.07
Poststreptococcal glomerulonephritis with pulmonary edema presenting as respiratory distress. Pediatr Nephrol (2004) 2.03
Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination. Gastroenterology (2012) 1.97
The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis (2002) 1.90
Neural pathogenesis of enterovirus 71 infection. Microbes Infect (2010) 1.66
Clinical and epidemiologic features of Coxsackievirus A6 infection in children in northern Taiwan between 2004 and 2009. J Microbiol Immunol Infect (2011) 1.64
A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy children. Vaccine (2002) 1.56
Clinical responses of patients with Kawasaki disease to different brands of intravenous immunoglobulin. J Pediatr (2006) 1.56
Tc17 CD8 T cells: functional plasticity and subset diversity. J Immunol (2009) 1.54
Is avian influenza A (H7N9) virus staggering its way to humans? J Formos Med Assoc (2013) 1.52
Nephromegaly is a significant risk factor for renal scarring in children with first febrile urinary tract infections. J Urol (2011) 1.51
Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71. Pediatr Res (2006) 1.50
Prevalence of methicillin-resistant Staphylococcus aureus nasal colonization among Taiwanese children in 2005 and 2006. J Clin Microbiol (2007) 1.48
Genomic signatures of influenza A pandemic (H1N1) 2009 virus. Emerg Infect Dis (2009) 1.48
hnRNP A1 interacts with the 5' untranslated regions of enterovirus 71 and Sindbis virus RNA and is required for viral replication. J Virol (2009) 1.41
Survey of short-term patient satisfaction after surgery for obstructive sleep apnea. Chang Gung Med J (2009) 1.40
Methicillin-resistant Staphylococcus aureus colonization and its association with infection among infants hospitalized in neonatal intensive care units. Pediatrics (2006) 1.40
The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology (2002) 1.40
Heterogeneous nuclear ribonuclear protein K interacts with the enterovirus 71 5' untranslated region and participates in virus replication. J Gen Virol (2008) 1.39
Taste disturbance after uvulopalatopharyngoplasty for obstructive sleep apnea. Otolaryngol Head Neck Surg (2006) 1.39
Community-acquired Pseudomonas aeruginosa sepsis in previously healthy infants and children: analysis of forty-three episodes. Pediatr Infect Dis J (2002) 1.37
Clinical features and genotyping analysis of community-acquired methicillin-resistant Staphylococcus aureus infections in Taiwanese children. Pediatr Infect Dis J (2005) 1.36
Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathog (2009) 1.36
Elevated cell-free serum DNA detected in patients with myocardial infarction. Clin Chim Acta (2003) 1.34
Changing molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates from a teaching hospital in Northern Taiwan. J Clin Microbiol (2006) 1.26
Laboratory-based surveillance and molecular epidemiology of influenza virus in Taiwan. J Clin Microbiol (2005) 1.26
Psychiatric morbidity and pregnancy outcome in a disaster area of Taiwan 921 earthquake. Psychiatry Clin Neurosci (2002) 1.24
Viral and host proteins involved in picornavirus life cycle. J Biomed Sci (2009) 1.24
Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71. Microbes Infect (2006) 1.23
Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compounds. J Biol Chem (2009) 1.23
Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy. Pediatrics (2008) 1.23
An investigation of epidemic enterovirus 71 infection in Taiwan, 2008: clinical, virologic, and serologic features. Pediatr Infect Dis J (2010) 1.22
Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient. J Virol (2005) 1.22
Molecular epidemiology of clinical isolates of methicillin-resistant Staphylococcus aureus in Taiwan. J Clin Microbiol (2004) 1.22
Outcome of enterovirus 71 infections with or without stage-based management: 1998 to 2002. Pediatr Infect Dis J (2004) 1.21
Factors associated with nasal colonization of methicillin-resistant Staphylococcus aureus among healthy children in Taiwan. J Clin Microbiol (2010) 1.21
Far upstream element binding protein 2 interacts with enterovirus 71 internal ribosomal entry site and negatively regulates viral translation. Nucleic Acids Res (2008) 1.20
Clinical manifestations and laboratory assessment in an enterovirus 71 outbreak in southern Taiwan. Scand J Infect Dis (2002) 1.19
Aurintricarboxylic acid inhibits influenza virus neuraminidase. Antiviral Res (2008) 1.19
Cross-reactive neutralizing antibody responses to enterovirus 71 infections in young children: implications for vaccine development. PLoS Negl Trop Dis (2013) 1.18
Characterization of a Vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate. Vaccine (2002) 1.18
Norovirus infection as a cause of diarrhea-associated benign infantile seizures. Clin Infect Dis (2009) 1.18
Nuclear export and import of human hepatitis B virus capsid protein and particles. PLoS Pathog (2010) 1.18
Nasal carriage of methicillin-resistant Staphylococcus aureus in school children without identifiable risk factors in northern taiwan. Pediatr Infect Dis J (2005) 1.18
Nasal carriage of methicillin-resistant Staphylococcus aureus in household contacts of children with community-acquired diseases in Taiwan. Pediatr Infect Dis J (2007) 1.17
Differential localization and function of PB1-F2 derived from different strains of influenza A virus. J Virol (2010) 1.17
HLA-A33 is associated with susceptibility to enterovirus 71 infection. Pediatrics (2008) 1.15
National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential. Vaccine (2009) 1.15
Development of ELISA on microplate for serum C-reactive protein and establishment of age-dependent normal reference range. Clin Chim Acta (2002) 1.14
Nasal carriage of methicillin-resistant Staphylococcus aureus in contacts of an adolescent with community-acquired disseminated disease. Pediatr Infect Dis J (2004) 1.14
Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival. PLoS One (2012) 1.14
Diverse apoptotic pathways in enterovirus 71-infected cells. J Neurovirol (2004) 1.13
Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adults. Hum Vaccin (2011) 1.12
Combining multiplex reverse transcription-PCR and a diagnostic microarray to detect and differentiate enterovirus 71 and coxsackievirus A16. J Clin Microbiol (2006) 1.12
Rhinolith from a plastic object in the nasal cavity for more than 20 years. Pediatr Int (2011) 1.11
Molecular evolution and the global reemergence of enterovirus D68 by genome-wide analysis. Medicine (Baltimore) (2016) 1.11
Determining the significance of coagulase-negative staphylococci identified in cultures of paired blood specimens from neonates by species identification and strain clonality. Infect Control Hosp Epidemiol (2006) 1.11
Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents. Bioorg Med Chem (2008) 1.10
Systematic phylogenetic analysis of influenza A virus reveals many novel mosaic genome segments. Infect Genet Evol (2013) 1.09
Viral and host factors that contribute to pathogenicity of enterovirus 71. Future Microbiol (2012) 1.09
Pott's puffy tumor in children. Childs Nerv Syst (2009) 1.08
Design, synthesis, and structure-activity relationship of pyridyl imidazolidinones: a novel class of potent and selective human enterovirus 71 inhibitors. J Med Chem (2002) 1.08
Severe adenovirus infection in children. J Microbiol Immunol Infect (2003) 1.08
Multiple genotypes of influenza B viruses cocirculated in Taiwan in 2004 and 2005. J Clin Microbiol (2007) 1.08
Imipenem heteroresistance induced by imipenem in multidrug-resistant Acinetobacter baumannii: mechanism and clinical implications. Int J Antimicrob Agents (2011) 1.08
Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma. J Nucl Med (2013) 1.08
Kawasaki disease in infants three months of age or younger. J Microbiol Immunol Infect (2006) 1.07
Comparison of clinical features between coxsackievirus A2 and enterovirus 71 during the enterovirus outbreak in Taiwan, 2008: a children's hospital experience. J Microbiol Immunol Infect (2010) 1.07
Genetic characterization of enterovirus 71 isolated from patients with severe disease by comparative analysis of complete genomes. J Med Virol (2012) 1.06
Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs). J Formos Med Assoc (2011) 1.06